Improvement of C peptide zero BMI 24-34 diabetic patients after tailored one anastomosis gastric bypass (BAGUA);Mejoría de pacientes diabéticos péptido C cero IMC 24-34 tras bypass gástrico una anastomosis (BAGUA) tallado

Nutricion Hospitalaria

Volumn 28, Issue SUPPL2, 2013, Pages 35-46

  Garciacaballero, M ^a   Martinez Moreno J M ^a   Toval, J A ^a   Miralles, F ^b   Minguez A ^a   Osorio, D ^a   Mata, J M ^a   Reyes Ortiz, A ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

C peptide; LADA; Metabolic syndrome; Micro and macro vascular diabetes complications; One anastomosis gastric bypass; T1DN

Indexed keywords

C PEPTIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BODY MASS; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; STOMACH BYPASS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84876423587     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2013.28.sup2.6568     Document Type: Article

References (45)

1. Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal T, Hemmingsen C, Wetterslev J. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev 2011; (6): CD008143.
2. Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassaï B, Erpeldinger S, Wright JM, Gueyffier F, Cornu C. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ 2011; 26: 343-345.
3. Realsen JM, Chase HP. Recent advances in the prevention of hypoglycemia in type 1 diabetes. Diabetes Technol Ther 2011; 13: 1177-1186.
4. Tanenberg RJ, Newton CA, Drake AJ. Confirmation of hypoglycemia in the "dead-in-bed" syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr Pract 2010; 16: 244-248.
5. McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND, Wermers RA, Smith SA. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care 2012; 35: 1897-901.
6. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 1983; 25: 496-501.
7. Jacobs J, Sena M, Fox N. The cost of hospitalization for the late complications of diabetes in the United States. Diabet Med 1991; 8: S23-S29.
8. García-Caballero M, Valle M, Martínez-Moreno JM, Miralles F, Toval JA, Mata JM, Osorio D, Mínguez A. Resolution of diabetes mellitus and metabolic syndrome in normal weight 24-29 BMI patients with one anastomosis gastric bypass. Nutr Hosp 2012; 27 (2): 633-664.
9. Reyes García R, Romero Muñoz M, Galbis Verdú H. Bariatric surgery in type 1 diabetes (spanish). Endocrinol Nutr 2013; 60 (1): 46-47.
10. Mendez C.E., Tanenberg R. J. and Pories W. Outcomes of Roux-en-Y gastric bypass surgery for severely obese patients with type 1 diabetes: a case series report. Diabetes, Metabolic Syndrome and Obesity. Targets and Therapy 2010; 3: 281-283.
11. Czupryniak L, Strzelczyk J, Cypryk K, Pawlowski, Maciej, et al. Gastric Bypass Surgery in Severely Obese Type 1 Diabetic Patients. Diabetes Care 2004; 27: 2561-2564.
12. Czupryniak L, Wiszniewski M, Szymanski D et al. Long-term results of gastric bypass surgery in morbidly obeses type 1 diabetes patients. Obes Surg 2010; 20: 506-508.
13. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248-256.
14. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366: 1567-1576.
15. 2: An integrated review of early studies. Obes Surg 2010; 20: 776-790.
16. Reis CE, Alvarez-Leite J, Bressan J, Alfenas RC. Role of Bariatric-Metabolic Surgery in the Treatment of Obese Type 2 Diabetes with Body Mass Index < 35. A Literature Review. Diabetes Technol Ther 2012; 14: 1-8.
17. García-Caballero M, Valle M, Martínez Moreno J, Miralles F, Toval JA, Mata JM, Osorio D, Minguez A. Resolution of diabetes mellitus and metabolic syndrome in normal weight 24-29 BMI patients with one anastomosis gastric bypass. Nutr Hosp 2012; 27: 623-631.
18. Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and metaanalysis. Surgery 2007; 142: 621-632.
19. Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. a systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg 2011; 253: 484-487.
20. Carlsson LM, Peltonen M, Ahlin S, Anveden Å, Bouchard C, Carlsson B, Jacobson P, Lönroth H, Maglio C, Näslund I, Pirazzi C, Romeo S, Sjöholm K, Sjöström E, Wedel H, Svensson PA, Sjöström L. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 2012; 367: 695-704.
21. Sjöholm K, Anveden A, Peltonen M, Jacobson P, Romeo S, Svensson PA, Sjöström L, Carlsson LM. Evaluation of Current Eligibility Criteria for Bariatric Surgery: Diabetes prevention and risk factor changes in the Swedish Obese Subjects (SOS) study. Diabetes Care 2013. [Epub ahead of print]
22. McVeigh GE, Gibson W, Hamilton PK. Cardiovascular risk in the young type 1 diabetes population with a low 10-year, but high lifetime risk of cardiovascular disease. Diabetes Obes Metab 2013; 15: 198-203.
23. Faber OK, Binder C. B-cell function and blood glucose control in insulin dependent diabetics within the first month of insulin treatment. Diabetologia 1977; 13: 263-268. (doi:10.1007/BF 01219710).
24. Steffes MW, Sibley S, Jackson M, Thomas W. Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 2003; 26832-2836. (doi:10.2337/diacare.26.3.832).
25. Palmer AJ, Roze S, Valentine WJ, Minshall ME, Lammert M, Oglesby A, Hayes C, Spinas GA. What impact would pancreatic beta-cell preservation have on life expectancy, quality-adjusted life expectancy and costs of complications in patients with type 2 diabetes? A projection using the CORE Diabetes Model. Current Medical Research and Opinion 2004: 20 (Suppl. 1): S59-S66.
26. Marchetti P, Lupi R, Del Guerra S, Bugliani M, D'Aleo V, Occhipinti M, Boggi U, Marselli L, Masini M. Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control. Diabetes Care 2009; 32 (Suppl. 2): S178-S183. (doi:10.2337/dc09-S306).
27. Sauerland S, Weiner S, Hausler E, Dolezalova K, Angrisani L, Noguera CM, Garcíacaballero M, Immenroth M. Validity of the Czech, German, Italian, and Spanish version of the Moorehead-Ardelt II questionnaire in patients with morbid obesity. Obes Facts 2009; 2 (Suppl. 1): 57-62.
28. Sauerland S, Angrisani L, Belachew M, Chevallier JM, Favretti F, Finer N, Fingerhut A, Garcia-Caballero M, Guisado Macias A, Mittermair R, Morino M, Msika S, Rubino F, Tacchino R, Weiner R, Neugebauer EA; European Association for Endoscopic Surgery. Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 2005; 19: 200-221.
29. García-Caballero M, Carbajo M. One anastomosis gastric bypass: a simple, safe and efficient surgical procedure for treating morbid obesity. Nutr Hosp 2004; 19: 372-375.
30. Tudurí E, Bruin JE, Kieffer TJ. Restoring insulin production for type 1 diabetes. J Diabetes 2012; 4: 319-331.
31. Franciosi M, Lucisano G, Amoretti R, Capani F, Bruttomesso D, Di Bartolo P, Girelli A, Leonetti F, Morviducci L, Vitacolonna E, Nicolucci A. Costs of treatment and complications of adult type 1 diabetes. Nutr Metab Cardiovasc Dis 2012; 29. [Epub ahead of print].
32. Allemann S, Saner C, Zwahlen M, Christ ER, Diem P, Stettler C. Long-term cardiovascular and non-cardiovascular mortality in women and men with type 1 and type 2 diabetes mellitus: a 30-year follow-up in Switzerland. Swiss Med Wkly 2009; 139: 576-583.
33. Garcíacaballero M. Type 2 diabetes surgery: A casual finding? Cir Esp 2010: 88: 355-357.
34. García-Caballero M, Martínez-Moreno JM, Toval JA, Miralles F, Mata JM, Osorio D, Mínguez A. Diabetes Mellitus with Metabolic Syndrome in BMI 24-29 vs 30-34 treated by One Anastomosis Gastric Bypass: is there differences in the results? XVII World Congress IFSO2012. 11-15 Sept New Delhi. Final Programme Book page 44.
35. García-Caballero M. Results of one anastomosis gastric bypass as treatment of diabetes mellitus type 2 in obese: its relation with surgical difficulty and prerioperative complitations. In: Diabetes Surgery. Garciacaballero M, Tinahones FJ, Cohen R (ed). McGraw-Hill. Madrid 2010. Pages:147-161.
36. Brophy S, Davies H, Mannan S, Brunt H, Williams R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database Syst Rev 2011; (9): CD006165.
37. Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects. Diabetes Care 2008; 31: 714-719.
38. Enzlin P, Rosen R, Wiegel M, Brown J, Wessells H, Gatcomb P, Rutledge B, Chan KL, Cleary PA; DCCT/EDIC Research Group. Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/EDIC study cohort. Diabetes Care 2009; 32 (5): 780-785.
39. Grauslund J. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes. Acta Ophthalmol 2011; 89 Thesis 1: 1-19.
40. Zhou H, Isaman DJ, Messinger S, Brown MB, Klein R, Brandle M, Herman WH. A computer simulation model of diabetes progression, quality of life, and cost. Diabetes Care 2005; 28 (12): 2856-2863.
41. Scopinaro N, Adami GF, Papadia FS, Camerini G, Carlini F, Fried M, Briatore L, D'Alessandro G, Andraghetti G, Cordera R. Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35. Ann Surg 2011; 253: 699-703.
42. Troy S, M Soty, Ribeiro L et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not gastric after lap-band in mice. Cell Metab 2008, 8: 201-211.
43. Delaere F, Magnan C, Mithieux G. Hypothalamic integration of portal glucose signals and control of food intake and insulin sensitivity. Diabetes & Metabolism 2010: 36: 257-262.
44. Hayes MT, Foo J, Besic V et al. Is intestinal gluconeogenesis a key factor in the early changes in glucose homeosatasis following gastric bypass? Obes Surg 2011; 21: 759-762.
45. Svelikova E, Zahiragic S, Pieber TE et al. Improved glucose metabolism early after gastric bypass surgery relies primarily on enhanced insulin sensitivity. Diabetologia 2011; 54 (Suppl. 1): S83.